ARCHIVES

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

This article is from The Cancer Letter archive.

Vol. 39 No. 26 | June 26, 2013

Download PDF Visit The Full Archive

Related Articles

PhRMA Offers Assistance For Part D “Doughnut Hole”

June 26, 2009

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

White House Order Poses Difficulties For NIH Peer Review

April 2, 1993

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004

Old MSK Grant Reprogrammed, NIC Makes Final 1985 Construction Awards

July 5, 1985

In Brief: NIH gives Advisors $50 Raise, Effective April 1, No Fooling

March 12, 1999